Core essentials of understanding iFR Co-registration
Updates into the latest updates in coronary interventions
Dr Yuetsu Kikuta is a Senior Consultant Cardiologist, Division of Cardiology, Fukuyama Cardiovascular Hospital,...
Dr Yuetsu Kikuta is a Senior Consultant Cardiologist, Division of Cardiology, Fukuyama Cardiovascular Hospital, Japan. He studied physiology as a Clinical Research Fellow (2015-2017) and a Faculty, Advances in Coronary Physiology under Dr Justin E Davies, MBBS, PhD, Imperial College London who invented iFR. He was the first author of the first-in-men international online iFR pullback GRADIENT registry (JACC CV Intv 2018). He was a co-author and an investigator of the DEFINE FLAIR study which showed noninferiority of iFR to FFR (NEJM 2017). He has written the protocol of and started the first-in-men randomized control trial of iFR-coregistration-guided revascularization compared to FFR-pullback guidance in patients with stable coronary artery disease with Prof. Hitoshi Matsuo at Gifu Heart Centre as PI since 2020. He has served as a core committee member of Japanese national PCI registry since 2018. His early mentor was Dr Hideo Tamai who developed the first human biodegradable coronary stent system (Igaki Tamai stent, Circulation 2000). He graduated from Kyoto University in 2002.